Related Experiment Video
Updated: Aug 12, 2026
07:54
Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
Published on: June 29, 2018
Comparison of long-term benzodiazepine users in three settings
C J Hawley1, M Tattersall, C Dellaportas
1Queen Elizabeth II Hospital, Welwyn Garden City, Herts.
The British Journal of Psychiatry : the Journal of Mental Science
|December 1, 1994
Summary
Chronic benzodiazepine users differ significantly. TRANX trial participants showed better outcomes than general practice or hospital patients, highlighting the need for individualized treatment plans.
Area of Science:
- Pharmacology
- Clinical Medicine
- Psychiatry
Background:
- Previous research on chronic benzodiazepine users often focused on unrepresentative patient groups.
- This study aimed to identify and analyze differences among distinct benzodiazepine-using populations.
Purpose of the Study:
- To investigate variations in characteristics and outcomes among different cohorts of chronic benzodiazepine users.
- To inform tailored management strategies for diverse patient profiles.
Main Methods:
- Comparative analysis of benzodiazepine users from general practice, hospital clinics, and TRANX trials.
- Collection of descriptive data on patient characteristics and treatment outcomes.
Main Results:
- Patients in TRANX trials demonstrated superior outcomes compared to other groups (P = 0.027).
- Hospital-based patients frequently used high-dose anxiolytic benzodiazepines and often had comorbid mental disorders, including schizophrenia.
- General practice patients were older and primarily used hypnotic benzodiazepines (P < 0.05).
Conclusions:
- Significant heterogeneity exists among different benzodiazepine user groups.
- A one-size-fits-all management approach is inappropriate; individual medical assessment is crucial for effective treatment.
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...